LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $5.82B
1-Year Est. Return 19.44%
This Quarter Est. Return
1 Year Est. Return
+19.44%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.23B
AUM Growth
+$525M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
98
New
Increased
Reduced
Closed

Top Buys

1 +$28.8M
2 +$25.7M
3 +$23M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$18.9M
5
AMRZ
Amrize Ltd
AMRZ
+$13.6M

Top Sells

1 +$40.9M
2 +$5.65M
3 +$3.5M
4
NTR icon
Nutrien
NTR
+$3.41M
5
C icon
Citigroup
C
+$2.88M

Sector Composition

1 Financials 34.05%
2 Communication Services 19.07%
3 Materials 11.57%
4 Healthcare 9.74%
5 Technology 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRY icon
76
ARS Pharmaceuticals
SPRY
$885M
$431K 0.01%
24,700
SKX
77
DELISTED
Skechers
SKX
$424K 0.01%
6,725
-648,075
FTS icon
78
Fortis
FTS
$26.6B
$405K 0.01%
8,500
EMA
79
Emera Inc
EMA
$14.3B
$388K 0.01%
+8,485
NXPI icon
80
NXP Semiconductors
NXPI
$51.4B
$388K 0.01%
+1,775
VALE icon
81
Vale
VALE
$53.3B
$356K 0.01%
36,650
MSFT icon
82
Microsoft
MSFT
$3.8T
$317K 0.01%
638
FCX icon
83
Freeport-McMoran
FCX
$60B
$300K 0.01%
+6,925
MGTX icon
84
MeiraGTx Holdings
MGTX
$697M
$295K 0.01%
45,300
ERO icon
85
Ero Copper
ERO
$2.37B
$244K ﹤0.01%
14,500
MLYS icon
86
Mineralys Therapeutics
MLYS
$3.67B
$223K ﹤0.01%
16,500
NAMS icon
87
NewAmsterdam Pharma
NAMS
$4.34B
$213K ﹤0.01%
+11,775
TCRX icon
88
TScan Therapeutics
TCRX
$67.5M
$139K ﹤0.01%
95,875
+18,775
AURA icon
89
Aura Biosciences
AURA
$346M
$133K ﹤0.01%
21,200
ETNB
90
DELISTED
89bio
ETNB
$105K ﹤0.01%
10,700
REPL icon
91
Replimune Group
REPL
$709M
$100K ﹤0.01%
+10,800
HUMA icon
92
Humacyte
HUMA
$234M
$96K ﹤0.01%
45,950
+21,150
ALDX icon
93
Aldeyra Therapeutics
ALDX
$319M
$66.3K ﹤0.01%
17,300
PLRX icon
94
Pliant Therapeutics
PLRX
$111M
-10,400
KMB icon
95
Kimberly-Clark
KMB
$34.6B
-1,515
IIF
96
Morgan Stanley India Investment Fund
IIF
$257M
-113,375
DUK icon
97
Duke Energy
DUK
$96.4B
-2,050
PROK icon
98
ProKidney
PROK
$364M
-15,900